Seeking to increase supply of Avigan, an influenza drug that may be effective against COVID-19, Fujifilm has signed up two pharmaceutical chemical outsourcing partners The Japanese firm Kaneka says it will begin supplying the drugâ€™s active ingredient, favipiravir, by July Another Japanese firm, Ube Industries, says it will make intermediates for the drug The Japanese government has ordered 2 million Avigan treatment courses View: PDF ;Full Text HTML